Intervention Review

Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke

  1. Philip MW Bath1,*,
  2. Mark M Willmot1,
  3. Jo Leonardi-Bee2,
  4. Fiona J Bath-Hextall3

Editorial Group: Cochrane Stroke Group

Published Online: 21 OCT 2002

Assessed as up-to-date: 12 AUG 2002

DOI: 10.1002/14651858.CD000398


How to Cite

Bath PMW, Willmot MM, Leonardi-Bee J, Bath-Hextall FJ. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD000398. DOI: 10.1002/14651858.CD000398.

Author Information

  1. 1

    University of Nottingham, Division of Stroke Medicine, Nottingham, UK

  2. 2

    The University of Nottingham, Division of Epidemiology and Public Health, Nottingham, UK

  3. 3

    The University of Nottingham, School of Nursing, Faculty of Medicine and Health Science, Nottingham, UK

*Philip MW Bath, Division of Stroke Medicine, University of Nottingham, South Block D Floor, Queens Medical Centre, Nottingham, NG7 2UH, UK. philip.bath@nottingham.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 OCT 2002

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Baseline characteristics of the 4011 patients recruited into the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial, International Journal of Stroke, 2014, 9, 6
  2. 2
    Siripan Phattanarudee, Pasarapa Towiwat, Timothy J. Maher, Ahmmed Ally, Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke, Canadian Journal of Physiology and Pharmacology, 2013, 91, 7, 510

    CrossRef

  3. 3
    Valérie Tikhonoff, Haifeng Zhang, Tom Richart, Jan A Staessen, Blood pressure as a prognostic factor after acute stroke, The Lancet Neurology, 2009, 8, 10, 938

    CrossRef

  4. 4
    Matthew Whiteman, Philip K. Moore, Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?, Journal of Cellular and Molecular Medicine, 2009, 13, 3
  5. 5
    Thomas Frietsch, Jeffrey R Kirsch, Strategies of neuroprotection for intracranial aneurysms, Best Practice & Research Clinical Anaesthesiology, 2004, 18, 4, 595

    CrossRef

  6. 6
    Lilia E Ziganshina, Tatyana Abakumova, Alexandra Kuchaeva, Cerebrolysin for acute ischaemic stroke, The Cochrane Library,
  7. 7
    Lilia E Ziganshina, Tatyana Abakumova, Alexandra Kuchaeva, Cerebrolysin for acute ischemic stroke, The Cochrane Library,
  8. 8
    Marco I Perez, Vijaya M Musini, James M Wright, Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event, The Cochrane Library,
  9. 9
    Chamila Geeganage, Philip MW Bath, Interventions for deliberately altering blood pressure in acute stroke, The Cochrane Library,
  10. 10
    Philip MW Bath, Kailash Krishnan, Interventions for deliberately altering blood pressure in acute stroke, The Cochrane Library,
  11. 11
    Chamila Geeganage, Philip MW Bath, Vasoactive drugs for acute stroke, The Cochrane Library,